Hyaluronic Acid Products Market
Hyaluronic Acid Products Market (Single-Injection, Three-Injection Cycle and Five-Injection Cycle) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
Press Release :
Global Hyaluronic Acid Products Market – Overview
Set to grow at a promising CAGR (Compound Annual Growth rate) of 9.20 % from 2013 to 2019, the global hyaluronic acid products market is on an upward growth trajectory. It will not only help the global hyaluronic acid products market witness surfacing of new and profitable opportunities but will also help it improve upon its market worth. The market valuation, as per Transparency Market Research, will reach the value of USD 9.85 bn.
Over the forecast period, North America would dominate the global hyaluronic acid products market owing to presence of strong players, and Asia Pacific would chart significant growth owing to an improving healthcare infrastructure.
Some of the factors that will shape the way the global hyaluronic acid products market in the future are outlined below:
- Number of people ageing is so high that in the year 2028, number of people aged 65 and above was more than the number of children aged five and below. Since the molecule if hyaluronic acid helps in drug delivery, wound repair, skin healing and so on, the geriatric demographic would be it important consumer base. By 2050, the world will witness one in six people in the 65 and above age group. In North America and Europe, the number would be one in four.
- Additionally, hyaluronic acid is an important cancer biomarker, particularly of breast and prostate cancer. It is important to note here that one nine men are a risk of developing prostate cancer. And, it is particularly true of older men who are at a higher risk. On the other hand, some 2.1 million women are impacted by breast cancer annually. This again underscores growth of global hyaluronic acid products market.
Global Hyaluronic Acid Products Market: Overview
Hyaluronic acid, one of the key components of the extracellular matrix (ECM), is a unique non-sulfated glycosaminoglycan that is well distributed across different types of tissues such as connective tissues, epithelial, and neural tissues. The molecule performs a variety of physiological functions and has wide applications in areas of drug delivery, skin healing, and wound repair, particularly fetal wound healing. It is also shown to have moderate the inflammation necessary for stabilizing the granulation tissue, thereby promoting healing. In recent years, the molecule have been used as a biomarker for various cancer types, especially that of prostate and breast. In addition, they can help in monitoring the disease progression. Since the molecule promotes normal cushioning of tissues and lubricates the joints, it has wide applications in orthopedic surgery. It also finds use in various eye surgeries, such as cataract removal and corneal transplantation.
With the rising prevalence of osteoarthritis, new uses of the molecule is being researched. Hyaluronic acid products are finding promising applications for reversing skin aging by modulating skin moisture. The rising demand for cosmetic treatment for aging skin is a key factors opening up exciting venues for the hyaluronic acid products market.
The global market for hyaluronic acid products is projected to rise at a CAGR of 9.2% between 2013 and 2019. The market is estimated to reach a valuation of US$9.85 bn by the end of the forecast period.
Single-Injection Cycle Treatment Gaining Preference
Based on the product, the hyaluronic acid products market is segmented into single-injection, three-injection, and five-injection cycle. In 2012, the five-injection cycle segment lead the overall products market. However, over the years it has lost some share. The demand for hyaluronic acid molecule as single-injection cycle treatment is preferred over five-injection cycles. This is attributed to the growing demand for convenience among patients and the pressing need to avoid adverse effects that may arise after being exposed to the treatment. Shifting to a lower-duration treatment can help patients avoid symptoms such as itching, redness, and inflammation, which may be common after every dose. In the coming years, the segment will rise at the major CAGR over the forecast period.
Vesicoureteral Reflux Segment to Reign Supreme
The major application segments of hyaluronic acid products market are dermal fillers, osteoarthritis, ophthalmic surgery, and vesicoureteral reflux (VUR). Of these, the dermal fillers application segment held the dominant share in 2012 closely followed by the osteoarthritis and vesicoureteral reflux (VUR) segments.
Meanwhile, the vesicoureteral reflux segment is projected to rise at the major CAGR over the forecast period. The spectacular pace of the growth of the segment is primarily driven by the rising demand for minimally-invasive surgical procedures. In addition, burgeoning aging population in several developed and developing nations who need eye and orthopedic surgeries is further fueling the demand for hyaluronic acid products.
Asia Pacific to Present Exciting Growth Avenues
On the basis of region, the market is segmented into North America, Asia Pacific, Europe, and Rest of the World (RoW). Of these, North America is the leading market holding the major regional share in 2012. The North America market is followed by that of Europe.
Meanwhile, Asia Pacific is projected to provide lucrative avenues for the growth of the market during the forecast period. The growth is propelled by vast improvements in the healthcare sector in recent years. In addition, the growing popularity of minimally invasive surgeries is a key trend expected to accentuate the regional market. The RoW is also predicted to provide significant opportunities for market players to capitalize on in the coming years.
Due to its significant contribution to proliferation and migration of cells, the global market for hyaluronic acid products has reported rapid expansion over the years. In 2012, the global market for hyaluronic acid products stood at US$5.32 billion and, according to the calculation of analysts at TMR, the market is rising at a CAGR of 9.2% over the period from 2013 to 2019 and is projected to reach US$9.85 billion by 2019.
The report studies the global market for hyaluronic acid products on the basis of the types of products, applications, and regional markets.
Based on product types, the markets for single-injection, three-injection, and five-injection cycles are the major segments of this market, while by application, the key market segments of the global hyaluronic acid products industry are the markets for dermal fillers, osteoarthritis, ophthalmic surgery, and vesicoureteral reflux (VUR).
Regionally, the hyaluronic acid products market is spread across the markets in North America, Asia Pacific, Europe, and the Rest of the World.
This report is prepared after extensive research carried out by market experts at TMR, considering the historic and current performance of the global market for hyaluronic acid products. Existing trends and future prospects of this market are also analyzed in detail in this study. The publication has considerable value for players, consultants, and stakeholders functioning in this market and will assist them in taking rewarding decision for their businesses.
Overview of the global market hyaluronic acid products
The global market for hyaluronic acid products is primarily driven by the rapid rise in the geriatric population all over the world, resulting in increasing demand for anti-ageing processes. The raised awareness among patients about the benefits of hyaluronic acid products and soaring demand for minimally invasive surgeries are also adding to the growth of this market.
Product-wise, the five-injection cycle market dominates the global market hyaluronic acid products industry at present. However, the single-injection market segment is reporting the highest growth rate during the forecast period.
By application, the market for dermal fillers leads the worldwide hyaluronic acid products market and is followed by the markets for osteoarthritis and vesicoureteral reflux. The application of hyaluronic acid products for vesicoureteral reflux is reporting the highest growth rate and is rising at a CAGR of 12.0% over the period of 2013-2019.
Regionally, the hyaluronic acid products market in North America accounts for the largest share in the global market and is followed by the market in Europe. Further, the market in Asia Pacific is identified as the most attractive hyaluronic acid products market over the forecast period.
Companies mentioned in the research report
Alcon, Inc., Anika Therapeutics, Inc., Allergan, Inc., F. Hoffmann-La Roche Ltd., Fidia Farmaceutici SpA, Ferring Pharmaceuticals, Inc., GALDERMA S.A., LifeCore Biomedical LLC, Hyaltech Ltd., Meiji Seika Pharma Co., Ltd., Sanofi, Merz Aesthetics, Inc., Salix Pharmaceuticals, Inc., Shanghai Jingfeng Pharmaceutical Co., Ltd., Seikagaku Corp., Smith & Nephew plc., Zimmer Holdings, Inc., and TRB Chemedica Int. SA are the major players operating in the global market for hyaluronic acid products.
Producers of hyaluronic acid products are extensively engaged in research and development with the aim of coming up with highly advanced and cost-effective products in order to gain a competitive edge over peers.
Key segments of the global market for hyaluronic acid products by products
- Single-injection Cycle
- Three-injection Cycle
- Five-injection Cycle
Key segments of the global market for hyaluronic acid products by application
- Ophthalmic Surgery
- Dermal Fillers
- Vesicoureteral Reflux (VUR)
Major geographies analyzed under this research report are:
- North America
- Rest of the World
This report gives you access to decisive data such as:
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for the coming years
Key highlights of this report
- Overview of key market forces propelling and restraining market growth
- Up-to-date analyses of market trends and technological improvements
- Pin-point analyses of market competition dynamics to offer you a competitive edge
- An analysis of strategies of major competitors
- An array of graphics and SWOT analysis of major industry segments
- Detailed analyses of industry trends
- A well-defined technological growth map with an impact-analysis
- Offers a clear understanding of the competitive landscape and key product segments